Patricia Ann Duffy

Array ( [id] => 32320 [patent_doc_number] => 07790452 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-09-07 [patent_title] => 'Artificial chimeras engineered to simulate multiple biological threat agents' [patent_app_type] => utility [patent_app_number] => 12/177527 [patent_app_country] => US [patent_app_date] => 2008-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5085 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790452.pdf [firstpage_image] =>[orig_patent_app_number] => 12177527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4463844 [patent_doc_number] => 07935503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-03 [patent_title] => 'Methods for producing and using polymyxins' [patent_app_type] => utility [patent_app_number] => 12/176684 [patent_app_country] => US [patent_app_date] => 2008-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6404 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/935/07935503.pdf [firstpage_image] =>[orig_patent_app_number] => 12176684 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5271505 [patent_doc_number] => 20090075281 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'MTBE GENES' [patent_app_type] => utility [patent_app_number] => 12/171244 [patent_app_country] => US [patent_app_date] => 2008-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 33 [patent_figures_cnt] => 33 [patent_no_of_words] => 24429 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0075/20090075281.pdf [firstpage_image] =>[orig_patent_app_number] => 12171244 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6454854 [patent_doc_number] => 20100189740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES' [patent_app_type] => utility [patent_app_number] => 12/664798 [patent_app_country] => US [patent_app_date] => 2008-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 17667 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0189/20100189740.pdf [firstpage_image] =>[orig_patent_app_number] => 12664798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5354696 [patent_doc_number] => 20090186040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-23 [patent_title] => 'DOSING METHODS FOR TREATING AUTOIMMUNE DISEASES USING A TACI-Ig FUSION PROTEIN SUCH AS ATACICEPT' [patent_app_type] => utility [patent_app_number] => 12/139078 [patent_app_country] => US [patent_app_date] => 2008-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 11502 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0186/20090186040.pdf [firstpage_image] =>[orig_patent_app_number] => 12139078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4792725 [patent_doc_number] => 20080293699 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-27 [patent_title] => 'Inhibitors of thapsigargin-induced cell death' [patent_app_type] => utility [patent_app_number] => 12/154544 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 26149 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0293/20080293699.pdf [firstpage_image] =>[orig_patent_app_number] => 12154544 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569387 [patent_doc_number] => 20090252765 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'BACILLE CALMETTE-GUERIN (BCG)-BASED ANTI-ATHEROMA VACCINE AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 12/122454 [patent_app_country] => US [patent_app_date] => 2008-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 12137 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252765.pdf [firstpage_image] =>[orig_patent_app_number] => 12122454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9299411 [patent_doc_number] => 08647633 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-02-11 [patent_title] => 'Recombinant F1-V plague vaccine' [patent_app_type] => utility [patent_app_number] => 12/115870 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7085 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12115870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9626002 [patent_doc_number] => 08795677 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-05 [patent_title] => 'Treatment methods using an F1-V plague vaccine' [patent_app_type] => utility [patent_app_number] => 12/115891 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 7091 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12115891 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10001438 [patent_doc_number] => 09045516 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Synthetic ligands for the differentiation of closely related toxins and pathogens' [patent_app_type] => utility [patent_app_number] => 12/104390 [patent_app_country] => US [patent_app_date] => 2008-04-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 6254 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12104390 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11804142 [patent_doc_number] => 09545086 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-17 [patent_title] => 'BAFF, inhibitors thereof and their use in the modulation of B-cell response and treatment of autoimmune disorders' [patent_app_type] => utility [patent_app_number] => 12/061398 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 56 [patent_no_of_words] => 20985 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12061398 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9777391 [patent_doc_number] => 08852591 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-07 [patent_title] => 'Combination of BLyS and/or APRIL inhibition and immunosuppressants for treatment of autoimmune disease' [patent_app_type] => utility [patent_app_number] => 12/057133 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 28081 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12057133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759328 [patent_doc_number] => 20080311554 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Methods for monitoring patients with severe sepsis and septic shock and for selecting treatments for these patients' [patent_app_type] => utility [patent_app_number] => 12/056367 [patent_app_country] => US [patent_app_date] => 2008-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18197 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311554.pdf [firstpage_image] =>[orig_patent_app_number] => 12056367 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4675802 [patent_doc_number] => 20080213431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'Use of lactic acid bacteria for improving food lysine absorption of pet animals' [patent_app_type] => utility [patent_app_number] => 12/072415 [patent_app_country] => US [patent_app_date] => 2008-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4080 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213431.pdf [firstpage_image] =>[orig_patent_app_number] => 12072415 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4826826 [patent_doc_number] => 20080125370 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-05-29 [patent_title] => 'USE OF GELSOLIN TO TREAT INFECTIONS' [patent_app_type] => utility [patent_app_number] => 12/026761 [patent_app_country] => US [patent_app_date] => 2008-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18502 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0125/20080125370.pdf [firstpage_image] =>[orig_patent_app_number] => 12026761 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4467999 [patent_doc_number] => 07943152 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-05-17 [patent_title] => 'Treatment of chronic chalazion and hordeolum with botulinum toxin' [patent_app_type] => utility [patent_app_number] => 12/010183 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1560 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/943/07943152.pdf [firstpage_image] =>[orig_patent_app_number] => 12010183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5569310 [patent_doc_number] => 20090252688 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Magnetic resonance contrast medium containing an iron-binding protein' [patent_app_type] => utility [patent_app_number] => 12/010135 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3752 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0252/20090252688.pdf [firstpage_image] =>[orig_patent_app_number] => 12010135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4949914 [patent_doc_number] => 20080306040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-11 [patent_title] => 'Antibacterial amide macrocycles VII' [patent_app_type] => utility [patent_app_number] => 12/008662 [patent_app_country] => US [patent_app_date] => 2008-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16032 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20080306040.pdf [firstpage_image] =>[orig_patent_app_number] => 12008662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8257500 [patent_doc_number] => 08206978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-06-26 [patent_title] => 'Green fluorescent protein optimized for expression with self-cleaving polypeptides' [patent_app_type] => utility [patent_app_number] => 12/521798 [patent_app_country] => US [patent_app_date] => 2007-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 8151 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12521798 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8652667 [patent_doc_number] => 08372413 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Immunomodulatory polynucleotides and methods of using the same' [patent_app_type] => utility [patent_app_number] => 11/963663 [patent_app_country] => US [patent_app_date] => 2007-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31219 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11963663 [rel_patent_id] =>[rel_patent_doc_number] =>)